Atlas Trials

Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease

Clinical trial NCT03664830 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03664830
Sponsor
City of Hope Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2018-09-19
Primary completion
2026-08-03
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.